Growth Strategies Case Study

Amgen's Growth Strategies

OR

Abstract:
Amgen, one of the world's leading biotechnology companies, had sales of $8.4 billion in 2003. Though the sales and profits of the company were higher than its competitors, it was lagging behind on the innovation front. Over the years the company grew with several mergers and acquisitions. It expected to achieve a turnover of $10 billion in 2004 and promised investors a 20% growth rate untill 2005.

Pedagogical Objectives:

• To discuss Amgen's growth strategies and the way it intends to achieve its promised growth.

Keywords : Mergers, Acquisitions, Alliances Case Study;Amgen's growth strategies; Biotechnology industry; Research and development; Genentech, Chiron Corporation, Biogen; Patent expiries; American pharmaceutical industry; Roger M Perlmutter; Kevin W Sharer; United States Food and Drug Administration; Generic competition; Mergers and acquisitions; Immunex Corporation; Joint ventures; Epogen, Enbrel, Aranesp, Erythropoietin, Johnson and Johnson

Contents : 
Amgen’s Growth Strategies
R&D Initiatives and Strategies
The Road Ahead
Amgen’s Financial Data
Amgen’s Best Selling Drugs
Amgen’s Commercial Potential in Clinical Development